Tudor Investment Corp’s Albany Molecular Research Inc AMRI Stock Holding History

Tudor Investment Corp’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,300	Closed	-$229K	–	1581
2017 Q1	$229K	Buy	+16,300	New	+$267K	0.01%	1161
2016 Q4	–	Sell	-14,744	Closed	-$243K	–	1755
2016 Q3	$243K	Buy	14,744 +2,244	+18%	+$33.2K	0.01%	1143
2016 Q2	$168K	Buy	+12,500	New	+$182K	﹤0.01%	1443
2016 Q1	–	Sell	-28,198	Closed	-$560K	–	2106
2015 Q4	$560K	Buy	28,198 +1,641	+6%	+$31.2K	0.02%	786
2015 Q3	$463K	Buy	+26,557	New	+$541K	0.02%	817
2015 Q2	–	Sell	-14,900	Closed	-$262K	–	1783
2015 Q1	$262K	Sell	14,900 -9,300	-38%	-$158K	0.01%	1130
2014 Q4	$394K	Buy	24,200 +7,945	+49%	+$146K	0.01%	877
2014 Q3	$359K	Buy	+16,255	New	+$333K	0.01%	892

Other funds holding AMRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Tudor Investment Corp's AMRI Position: Q2 2017 in Review

Tudor Investment Corp sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 16,300 shares — an estimated $229K sold.

Tudor Investment Corp first reported a position in AMRI in Q3 2014 and held it in 8 quarters. The position peaked at $560K in Q4 2015. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

Tudor Investment Corp reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
Tudor Investment Corp sold 16,300 Albany Molecular Research Inc shares in Q2 2017, an estimated $229K.
Tudor Investment Corp first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 8 quarters.
Tudor Investment Corp's Albany Molecular Research Inc position peaked at $560K in Q4 2015.
136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Tudor Investment Corp's 13F filing for Q2 2017, filed 14 Aug 2017.